Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Paulissen, N. Rocks, M. Gueders, C. Crahay, F. Quesada-Calvo, J. Hacha, S. Bekaert, C. Desmet, J. M. Foidart, F. Bureau, A. Noel, D. Cataldo (Liege, Belgium). ADAM-8 metalloproteinase drives acute allergen-induced airway inflammation. Eur Respir J 2010; 36: Suppl. 54, 1346

Member's Comments

No comment yet.

Related content which might interest you: Control of allergen-induced inflammation and hyperresponsiveness by the metalloproteinase ADAMTS-12 Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Matrix metalloproteinase-8 deletion promotes allergen-induced airway inflammation in mice Source: Eur Respir J 2004; 24: Suppl. 48, 659s Year: 2004 Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside Year: 2007 MMP-9 and airway neutrophilia Source: Annual Congress 2004 - Inflammation and remodelling in human lungs Year: 2004 Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001 High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010 MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2001; 18: Suppl. 33, 20s Year: 2001 Airway epithelial cell P2Y6R-Expression is up-regulated during acute and chronic allergic inflammation and contributes via modulating of CXC8 and IL-6 secretion to development of airway remodelling Source: Annual Congress 2010 - Pre-clinical models of airways disease Year: 2010 Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats Source: Eur Respir J 2006; 27: 726-734 Year: 2006 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 The role of CCR5 in allergen-induced airway hyperresponsiveness and airway inflammation Source: Annual Congress 2009 - Animal models of airways inflammation Year: 2009 Smooth-muscle-derived WNT-5A drives allergen-induced remodelling and Th2 type inflammation Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control Year: 2018 Role of IL-33 signaling in pollutant-induced allergic airway inflammation Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018 CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice Source: Annual Congress 2011 - Animal models of airway inflammation Year: 2011 Allergen-induced airway remodelling Source: Eur Respir J 2007; 29: 1020-1032 Year: 2007 IL-33 blockade prevents exacerbations in a model of chronic airway inflammation by blunting persistent inflammation and remodeling Source: International Congress 2019 – Advances in asthma pharmacology Year: 2019 Arginase in airway inflammation and remodelling Source: Annual Congress 2004 - Arginase: a novel target and marker for asthma? Year: 2004